Oxcarbazepine

Product manufactured by Cardinal Health

Application Nr Approved Date Route Status External Links
ANDA078069 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Oxcarbazepine Tablets Are Indicated For Use As Monotherapy Or Adjunctive Therapy In The Treatment Of Partial Seizures In Adults And As Monotherapy In The Treatment Of Partial Seizures In Pediatric Patients Aged 4 Years And Above With Epilepsy, And As Adjunctive Therapy In Pediatric Patients Aged 2 Years And Above With Partial Seizures. Oxcarbazepine Tablets Are Indicated For: • Adults: Monotherapy Or Adjunctive Therapy In The Treatment Of Partial Seizures • Pediatrics: • Monotherapy In The Treatment Of Partial Seizures In Children 4-16 Years • Adjunctive Therapy In The Treatment Of Partial Seizures In Children 2-16 Years ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Oxcarbazepine OXCARBAZEPINE ZINC4724

Comments